Niederer Kraft Frey advised L Catterton on the deal. Walder Wyss advised Planted Foods AG. Planted, a Kemptthal, Switzerland-based foodtech startup known for its clean-label biostructured...
Planted Foods AG’s CHF 70 Million Series B Financing Round
Swiss Life’s €700 Million Senior Bond Placement
Walder Wyss acted as legal counsel to Swiss Life on this transaction. Swiss Life successfully placed a EUR 700 million senior bond on 23 August 2022,...
Clariant’s CHF 175 Million Green Bond Offering
Walder Wyss acted as counsel to Clariant in this transaction. Clariant (SIX: CLN) successfully placed its first Green Bond. The CHF 175 million Green Bond has...
Dätwyler Group’s USD 175 Million Syndicated Credit Facility
Walder Wyss advised UBS Switzerland AG and the other syndicate banks on the deal., while Homburger advised Dätwyler Holding AG and Datwyler Parco Holdings, Inc. UBS...
Infront’s Acquisition of Assetmax
Bär & Karrer advised Infront AS in this transaction. Walder Wyss advised the shareholders of Assetmax. Infront AS has signed an agreement for the acquisition of...
Vector BioPharma’s USD 30 Million Series A Funding Round
Walder Wyss advised Versant Ventures on the deal. Versant Ventures announced the debut of Vector BioPharma, a biopharmaceutical company developing a precision gene delivery platform that...
Pepperdine University’s Sale and Lease-back of Its Campus Property in Lausanne
Walder Wyss advised Pepperdine University on the deal. Pepperdine University announced the sale and lease-back of its property located on Avenue Marc-Dufour to LO Immeubles SA...
xFarm Technologies’ €17 Million Series B Funding Round
Bär & Karrer and Colla Di Piazza Studio Legale have assisted xFarm Technologies in this transaction, while id est avocats advised Swisscom Ventures. Pavia e Ansaldo...
AEW Energie AG’s CHF 125 Million Bond Offering
Walder Wyss advised AEW Energie AG on the deal. AEW Energie AG issued a CHF 125m fixed rate straight bond with a 7 years term and...
Ufenau Capital Partners’ Investment in Dr. Niedermaier Pharma Group
GÖRG Partnerschaft von Rechtsanwälten mbB and Walder Wyss advised Ufenau Capital Partners on the deal. Ufenau Capital Partners announced the investment in the Dr. Niedermaier Pharma Group....
Pexapark’s €8 Million Second Round of Its Series B Funding
Walder Wyss advised Pexpark in this transaction. Pexapark announced that it has secured an additional €8 million in its Series B funding round from its existing...
ELSA’s Bid For The Acquisition of a Stake in Aaremilch
Walder Wyss advised ELSA on this transaction. ELSA, a milk processing company belonging to the Migros Group, intends to invest in the procurement of raw materials...